Integer Holdings Corporation Common Stock (ITGR)
Healthcare › Electromedical & Electrotherapeutic Apparatus
Price History
Feb 9, 2026 — Aug 11, 2026Investment Snapshot
- Trading 46% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 6.8% — below-average profitability
- Revenue growing at 8% annually
Integer Holdings Corporation Common Stock (ITGR) is a Healthcare company operating in Electromedical & Electrotherapeutic Apparatus, listed on the NYSE , with a market capitalisation of $3.1 billion . Key value metrics: P/E ratio 26.6, P/B ratio 1.81, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Integer Holdings Corporation Common Stock — Fundamental Analysis Summary
Integer Holdings Corporation Common Stock (ITGR) is currently trading 46% above its Graham Number of $62.52, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 26.6x.
On financial health, ITGR shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 6.8% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.72.
StockPik's composite Value Score for ITGR is 62/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ITGR reports a moderate gross margin of 25.9% (sector average: 37.4%) and a modest operating margin of 9.9%.
ITGR shows revenue growing at 8% year-over-year, with earnings declining at 14%.